Role of Ropivacaine in the management of post-operative pain.
Phase 1
- Conditions
- Health Condition 1: K87- Disorders of gallbladder, biliarytract and pancreas in diseases classified elsewhere
- Registration Number
- CTRI/2020/06/025565
- Lead Sponsor
- Dr Anil Agarwal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Adult patients of either sex, ASA physical status I or II, who are scheduled for abdominal surgery under general anaesthesia and thoracic epidural analgesia, will be included in the study.
Exclusion Criteria
Patient refusal and patients who are unable to understand the numerical rating scale for pain assessment, will be excluded in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Post-operative NRS score for dynamic pain(coughing)Timepoint: At 0(zero) hours, 6 hours, 12 hours, 18 hours, 24 hours, 30 hours, 36 hours, 42 hours, 48 hours, 54 hours,60 hours, 66 hours, 72 hours.
- Secondary Outcome Measures
Name Time Method Post-operative nausea and vomiting (PONV), reqirement of rescue analgesia and rescue anti-emetic, hypotension, motor block, sedation, pruritis and respiratory depression.Timepoint: At 0(zero) hours, 6 hours, 12 hours, 18 hours, 24 hours, 30 hours, 36 hours, 42 hours, 48 hours, 54 hours, 60 hours, 66 hours, 72 hours.